Aortic Stenosis Treatment companies

Report ID: 3125
Published Date: Sep 09, 2025
Report Format: PDF, PPT

Buy Now

Key Aortic Stenosis Treatment Market Players:

The global market is highly competitive and is led by multiple key players such as Edwards Lifesciences and Medtronic. These players collectively hold a significant share and are driven by the enhanced TAVR platforms and global distribution. Companies are focusing on product innovation, regulatory expansion, and strategic collaboration to be competitive in the market. Companies, including Boston Scientific and Abbott, are actively investing in next-gen value systems and AI-enabled delivery tools. On the other hand, the Asia Pacific layers are scaling regulatory and manufacturing reach. The market is redefined by the local R&D, government-backed infrastructure, and value-based pricing.

Here is a list of key players operating in the global aortic stenosis treatment market:

Edwards Lifesciences
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
JenaValve Technology
Terumo Corporation
MicroPort Scientific
CryoLife (now Artivion)
Biotronik
Lepu Medical
LivaNova
NVT AG
Sahajanand Medical Technologies
Transcatheter Technologies GmbH
Admedus
Osypka Medical
Scinomed Lifecare
Taewoong Medical
Malaysian Bio-XCell
B. Braun Melsungen AG

Browse key industry insights with market data tables & charts from the report:

Aortic Stenosis Treatment Market Size, Growth Trends 2026-2035

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of aortic stenosis treatment is assessed at USD 24.6 billion.

Aortic Stenosis Treatment Market size was valued at USD 9.42 billion in 2025 and is expected to reach USD 25 billion by 2035, registering around 10.3% CAGR during the forecast period i.e., between 2026-2035.

The aortic stenosis treatment market in North America dominates the market and is expected to hold the market share of 43.8% at a CAGR of 8.5% by 2035.

The major players in the market are Edwards Lifesciences Corporation, Neovasc Inc., HighLife SAS, Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, CryoLife Inc., Siemens Healthcare GmbH, and others.